
    
      The study population consists of pacemaker-free patients that are 18 years or older
      undergoing a TAVI with new onset left bundle branch block. Patient consent is required.

      Patients meeting the inclusion criteria will be randomized in a 1:1 ratio to one of the
      following two groups:

      Group 1: electrophysiology-based algorithmic approach

      Group 2: standard clinical follow-up with transcutaneous cardiac monitoring.
    
  